R2 Technology receives FDA approval on OmniCAD
The FDA has given the green light for R2 Technology Inc. to market its Image CheckerDM computer-aided detection (CAD) system with OmniCAD technology.
OmniCAD's open-architecture design allows the ImageChecker system to review either film or digital mammograms. It also provides CAD and other computer analysis for a range of imaging modalities, such as film-based and digital mammography and CT.
R2 has partnered with GE Medical Systems (GEMS) to incorporate the CAD system with GEMS' Senographe 2000D. Future partnerships with other full-field digital mammography (FFDM) systems are anticipated with systems from Fischer Imaging Corp., Hologic Inc., and Siemens Medical Solutions.
R2 Technology also is developing plans to integrate with reporting companies and RIS (radiology information system) providers.
OmniCAD's open-architecture design allows the ImageChecker system to review either film or digital mammograms. It also provides CAD and other computer analysis for a range of imaging modalities, such as film-based and digital mammography and CT.
R2 has partnered with GE Medical Systems (GEMS) to incorporate the CAD system with GEMS' Senographe 2000D. Future partnerships with other full-field digital mammography (FFDM) systems are anticipated with systems from Fischer Imaging Corp., Hologic Inc., and Siemens Medical Solutions.
R2 Technology also is developing plans to integrate with reporting companies and RIS (radiology information system) providers.